- Home
- MTCH vs BIO Comparison
MTCH vs BIO Comparison
Compare MTCH & BIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MTCH
- BIO
- Stock Information
- Founded
- MTCH 1986
- BIO 1952
- Country
- MTCH United States
- BIO United States
- Employees
- MTCH N/A
- BIO N/A
- Industry
- MTCH Computer Software: Programming Data Processing
- BIO Biotechnology: Laboratory Analytical Instruments
- Sector
- MTCH Technology
- BIO Industrials
- Exchange
- MTCH Nasdaq
- BIO Nasdaq
- Market Cap
- MTCH 8.2B
- BIO 7.7B
- IPO Year
- MTCH 2015
- BIO N/A
- Fundamental
- Price
- MTCH $37.59
- BIO $280.82
- Analyst Decision
- MTCH Hold
- BIO Strong Buy
- Analyst Count
- MTCH 16
- BIO 4
- Target Price
- MTCH $35.44
- BIO $333.50
- AVG Volume (30 Days)
- MTCH 3.4M
- BIO 227.8K
- Earning Date
- MTCH 11-05-2025
- BIO 10-29-2025
- Dividend Yield
- MTCH 2.02%
- BIO N/A
- EPS Growth
- MTCH N/A
- BIO N/A
- EPS
- MTCH 2.03
- BIO 11.49
- Revenue
- MTCH $3,450,576,000.00
- BIO $2,554,200,000.00
- Revenue This Year
- MTCH $2.43
- BIO $2.12
- Revenue Next Year
- MTCH $4.49
- BIO $2.90
- P/E Ratio
- MTCH $18.48
- BIO $24.56
- Revenue Growth
- MTCH N/A
- BIO N/A
- 52 Week Low
- MTCH $26.39
- BIO $211.43
- 52 Week High
- MTCH $39.20
- BIO $387.99
- Technical
- Relative Strength Index (RSI)
- MTCH 54.84
- BIO 48.64
- Support Level
- MTCH $37.06
- BIO $277.40
- Resistance Level
- MTCH $38.35
- BIO $298.00
- Average True Range (ATR)
- MTCH 0.81
- BIO 7.85
- MACD
- MTCH -0.18
- BIO -2.53
- Stochastic Oscillator
- MTCH 45.65
- BIO 17.78
About MTCH Match Group Inc.
Match Group Inc is a provider of online dating products. The company's portfolio of brands includes Tinder, Hinge, Match, Meetic, OkCupid, Pairs, Plenty Of Fish, Azar, BLK, and more, each built to increase its user's likelihood of connecting with others. The company has four operating segments: Tinder, Hinge, Evergreen and Emerging, and Match Group Asia. The company generates the majority of its revenue from the Tinder segment.
About BIO Bio-Rad Laboratories Inc.
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.